Phencyclidine (PCP), known on the street as angel dust, is the arylcyclohexylamine that wrote the rulebook -- the compound against which every subsequent dissociative has been measured, feared, and pharmacologically compared. First synthesized in 1926 by Arthur Kotz and Paul Merkel as a curiosity of Grignard chemistry, it was independently rediscovered in 1956 and developed by Parke-Davis as a surgical anesthetic under the brand name Sernyl. It was an effective anesthetic. It was also, as clinical trials would reveal, capable of producing postoperative psychosis so severe that one-sixth of patients given anesthetic doses emerged into states of delirium, paranoia, and agitation that could take a week or more to resolve. Human medical use was discontinued in 1965. Veterinary use under the name Sernylan continued until 1978. And somewhere in between, PCP escaped into the street drug supply and became the most notorious dissociative substance in history.
PCP's notoriety is not unearned, but it is worth understanding what is pharmacologically real versus what is urban legend. The real dangers: PCP is a potent NMDA receptor antagonist with significant D2 dopamine receptor agonism, sigma receptor activity, and serotonin reuptake inhibition. This combination -- dissociation plus dopaminergic stimulation plus sigma agonism -- produces a state unlike any other dissociative: driven, manic, physically empowered, profoundly disconnected from pain and consequence, and at high doses or in susceptible individuals, frankly psychotic. The compound is highly lipophilic, accumulates in fat tissue, and releases slowly over days, meaning that PCP intoxication can last far longer than expected and can produce unpredictable recurrence of effects as the drug mobilizes from adipose stores.
The urban legends -- that PCP gives users literal superhuman strength, that it makes people impervious to bullets, that a single dose turns someone into a violent maniac -- are exaggerations of real pharmacological phenomena. PCP abolishes pain perception, produces extreme agitation and manic energy, and severely impairs judgment, which means PCP-intoxicated individuals may exert themselves far beyond normal limits, sustain injuries without awareness, and resist restraint with alarming endurance. They are not superhuman. They are human beings operating without the biological safety limiters -- pain, fatigue, fear -- that normally prevent us from destroying ourselves.
PCP's scientific legacy is substantial. Its ability to reproduce both positive and negative symptoms of schizophrenia -- something no other drug class does as completely -- was instrumental in developing the glutamate hypothesis of schizophrenia, one of the most important frameworks in modern psychiatric research. Ketamine was developed specifically as a safer alternative to PCP, and the entire arylcyclohexylamine class of research chemicals (MXE, 3-MeO-PCP, DCK, and dozens of others) exists in PCP's pharmacological shadow. Schedule II in the United States, Class A in the United Kingdom, and controlled internationally, PCP remains one of the few dissociatives with sustained street-level availability, particularly in certain US urban communities.
Safety at a Glance
High Risk- Understand What You Are Dealing With
- Dosing: Milligram Scale, No Exceptions
- Toxicity: Acute Physical Toxicity PCP's most dangerous acute effects are dose-dependent and include severe hypertension (which ...
- Dangerous with: 2C-T-x, 5-MeO-DALT, 5-MeO-DiPT, 5-MeO-DMT, 2-FA, 2-FMA, 3-FA (+21 more)
- Overdose risk: PCP overdose is a medical emergency that can be fatal. The most dangerous complications are seizu...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
smoked
oral
Duration
insufflated
Total: 4 hrs – 6 hrssmoked
Total: 4 hrs – 6 hrsoral
Total: 4 hrs – 8 hrsHow It Feels
It begins with a numbness so total it feels like a philosophical statement -- the body does not merely lose sensation but seems to declare sensation unnecessary, a relic of a more limited form of consciousness. Within fifteen minutes the numbness has reached the core, and with it comes a surge of power: raw, undifferentiated, almost electrical, as though the body has been plugged into a source of energy that operates without the usual safety limiters. Your limbs feel capable of anything. Pain is not dulled -- it has been abolished, categorically, as though the concept itself has been removed from the operating system.
The come-up is rapid and overwhelming. The stimulation builds into something that transcends ordinary energy and becomes a kind of possession -- a driven, relentless momentum that infects every thought and every movement. You walk and the walk becomes a march. You speak and the speech becomes a proclamation. There is a grandiosity here that is legendary for good reason: you do not merely feel confident, you feel chosen, anointed, operating on a plane of reality that the people around you cannot perceive. Sound takes on an artificial, processed quality, as though the world is being broadcast through a cheap speaker at enormous volume. Vision narrows into a tunnel of absolute focus.
At the peak, PCP produces a state that has no real parallel among other dissociatives. The dissociation and the stimulation and the mania fuse into a single overwhelming experience of detached omnipotence. You are, simultaneously, nowhere and everywhere -- removed from your body yet capable of directing it with terrifying force. Reality has been replaced by a narrative in which you are the central figure, and every element of the environment has been recruited into this narrative as either ally or obstacle. At high doses, the paranoia can become total, and the conviction absolute. The body is a machine running without governors: pain-free, fatigue-free, and operating with a strength and endurance that will exact its cost later, when the compound withdraws its support.
The descent is brutal and protracted. The omnipotence drains away first, leaving behind the stimulation and the paranoia, now stripped of their grandiose context and simply unpleasant. You are wired, suspicious, and unable to sleep. The body, which has been performing without complaint for hours, begins to report the accumulated damage: muscle soreness, joint pain, injuries sustained without awareness. The emotional crash can be severe -- a flat, hostile depression that settles in like weather and may persist for days. PCP does not leave gracefully. It leaves the way a storm leaves: with wreckage to assess, repairs to make, and the slow, humbling work of returning to ordinary human scale.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(12)
- Appetite enhancement— A distinct increase in hunger and desire for food, often accompanied by enhanced enjoyment of taste ...
- Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
- Perception of bodily lightness— Perception of bodily lightness is the subjective feeling that one's body has become dramatically lig...
- Physical autonomy— Physical autonomy is the experience of one's body performing actions — from simple tasks like walkin...
- Physical disconnection— A perceptual distancing from one's own physical body that ranges from a subtle sense of numbness or ...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Tactile(2)
- Tactile distortion— Tactile distortion is the warping of existing touch and body sensations — textures may feel alien, p...
- Tactile suppression— A progressive decrease in the ability to feel physical touch, ranging from mild numbness to complete...
Cognitive & Perceptual Effects
Visual(12)
- Colour suppression— A visual effect in which the perceived saturation and vibrancy of colors is diminished, causing the ...
- Double vision— The visual experience of seeing a single object as two separate, overlapping images, similar to cros...
- Environmental cubism— A visual distortion in which the environment and objects within it appear fragmented into geometric,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Frame rate suppression— Perception of visual motion as choppy discrete frames rather than smooth continuous flow, resembling...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Perspective distortions— Distortion of perceived depth, distance, and size of real objects, making things appear closer, furt...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Visual acuity suppression— Vision becomes blurred, indistinct, and out of focus, as though looking through a smudged lens. Fine...
- Visual agnosia— A dissociative visual-cognitive effect in which the observer can physically see objects with normal ...
- Visual disconnection— A dissociative visual effect involving a progressive detachment from visual perception, ranging from...
Cognitive(31)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Analysis suppression— Analysis suppression is a cognitive impairment in which the capacity for logical reasoning, critical...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Anxiety suppression— A partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental st...
- Cognitive disconnection— Cognitive disconnection is the experience of feeling profoundly detached from one's own thoughts, se...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Creativity enhancement— An increase in the ability to imagine new ideas, overcome creative blocks, think about existing conc...
- Deja vu— Intense, often prolonged sensation of having already experienced the current moment, common with psy...
- Delirium— Delirium is a serious and potentially dangerous state of acute mental confusion involving disorienta...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Depersonalization— A detachment from one's own sense of self, body, or mental processes, as if observing oneself from o...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Derealization— A perceptual disturbance in which the external world feels profoundly unreal, dreamlike, or artifici...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
- Ego inflation— Grandiose overconfidence and inflated self-importance, opposite of ego death, commonly produced by s...
- Feelings of impending doom— Feelings of impending doom is the sudden onset of an overwhelming, visceral certainty that something...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Jamais vu— Jamais vu is the unsettling experience of encountering something deeply familiar — a word, a place, ...
- Mania— Abnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated w...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Suicidal ideation— Suicidal ideation is the emergence of thoughts, urges, or preoccupations centered on ending one's ow...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought connectivity— A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconne...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Thought disorganization— Thought disorganization is a cognitive impairment in which the normal capacity for structured, seque...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
Auditory(4)
- Auditory distortion— Auditory distortion is the experience of sounds becoming warped, pitch-shifted, flanged, or otherwis...
- Auditory hallucination— Auditory hallucination is the perception of sounds that have no external source — hearing music, voi...
- Auditory misinterpretation— Auditory misinterpretation is the brief, spontaneous misidentification of real sounds as entirely di...
- Auditory suppression— A dampening of auditory perception in which sounds become muffled, distant, and reduced in both volu...
Transpersonal(1)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
Pharmacology
NMDA Receptor Antagonism
PCP's primary mechanism of action is non-competitive antagonism of the NMDA glutamate receptor -- binding within the ion channel at what is literally called "the PCP site," the binding pocket that was named after the molecule. PCP blocks the flow of calcium and sodium ions through the NMDA receptor channel, disrupting excitatory neurotransmission throughout the central nervous system. This produces the core dissociative effects: disconnection from sensory input, anesthesia, ataxia, and at high doses, the subjective experience of complete separation from body and environment. PCP is more potent and substantially longer-acting at the NMDA receptor than ketamine.
Dopamine D2 Receptor Agonism
This is the pharmacological feature that separates PCP from ketamine and most other dissociatives. PCP acts as a potent direct agonist at D2 dopamine receptors -- not merely a dopamine reuptake inhibitor but an activator of the receptor itself. This produces powerful stimulation, euphoria, grandiosity, and at higher activation levels, the mania and psychosis for which PCP is infamous. The D2 agonism is why PCP feels driven and empowering where ketamine feels sedating and introspective. It is also why PCP is substantially more addictive and more likely to produce psychotic states than other NMDA antagonists.
Sigma Receptor Activity
PCP has significant affinity for sigma-1 and sigma-2 receptors. Sigma receptor agonism contributes additional stimulant, dissociative, and psychotomimetic effects, and likely synergizes with the D2 agonism to produce PCP's characteristic manic quality. The sigma system is also implicated in the drug's analgesic properties and its interactions with the opioid system.
Additional Targets
PCP also acts as a serotonin reuptake inhibitor (contributing to mood effects and serotonin-related toxicity risk), has activity at nicotinic acetylcholine receptors, and shows affinity for the PCP2 glutamate receptor -- a relatively unstudied site that PCP shares with 3-MeO-PCP but not with ketamine. The breadth of this pharmacological profile -- NMDA antagonism, D2 agonism, sigma agonism, serotonin reuptake inhibition, and multiple secondary targets -- accounts for PCP's complex, unpredictable, and often overwhelming effects.
Pharmacokinetics and Lipophilicity
PCP is highly lipophilic and can be absorbed through the skin, mucous membranes, and lungs with high efficiency. When smoked (the most common street route), onset is within 2-5 minutes. Oral onset is 30-60 minutes. The drug distributes extensively into adipose tissue, creating a reservoir that releases PCP slowly back into the bloodstream. This is why PCP effects can last 4-8 hours acutely, with residual effects and potential recurrence ("flashbacks") extending for days. In chronic users, PCP can remain detectable in urine for 2-4 weeks due to gradual mobilization from fat stores. The terminal elimination half-life ranges from 7 to 46 hours depending on dose, route, and urine pH.
Detection Methods
Standard Drug Panel Inclusion
PCP (phencyclidine) IS included on the standard 5-panel drug test, making it one of the most commonly screened substances in workplace and clinical drug testing. The standard immunoassay cutoff for PCP in urine is 25 ng/mL. PCP has been included on drug screening panels since the earliest days of workplace drug testing and remains a mandatory analyte in most testing programs.
Urine Detection
PCP is detectable in urine for approximately 3 to 7 days after a single dose in occasional users. In chronic, heavy users, PCP can remain detectable for 2 to 4 weeks due to its high lipophilicity and accumulation in adipose tissue. The compound undergoes extensive hepatic metabolism via oxidative hydroxylation, producing multiple metabolites. However, approximately 10 to 15 percent of a dose is excreted unchanged in urine, which is the primary target of immunoassay screening. Urinary excretion is pH-dependent, with acidic urine significantly increasing clearance rates.
Blood and Serum Detection
Blood detection windows are 1 to 3 days for single use and up to 1 to 2 weeks for chronic use. Pharmacologically active blood concentrations range from 7 to 240 ng/mL. Concentrations above 100 ng/mL are associated with severe toxicity including coma and seizures.
Hair Follicle Detection
Hair testing detects PCP for up to 90 days. PCP is a basic compound that incorporates readily into the hair shaft, and detection in hair is well established. Both the parent compound and metabolites are targeted.
Confirmatory Methods
GC-MS and LC-MS/MS are used for confirmation. GC-MS is the traditional reference method, providing definitive identification with characteristic mass spectral fragmentation. LC-MS/MS offers improved sensitivity and the ability to simultaneously screen for PCP analogues. The standard confirmatory cutoff is 25 ng/mL, matching the screening cutoff.
Reagent Testing
The Marquis reagent produces no significant reaction with PCP. The Mandelin reagent yields an orange-brown color. The Mecke reagent may produce a faint yellow-green response. The Simon reagent, which detects secondary amines, produces a blue color with PCP. Fentanyl test strips should be used on any PCP obtained from unregulated sources.
Interactions
| Substance | Status | Note |
|---|---|---|
| 2C-T-x | Dangerous | — |
| 5-MeO-DALT | Dangerous | — |
| 5-MeO-DiPT | Dangerous | — |
| 5-MeO-DMT | Dangerous | — |
| 5-MeO-MiPT | Dangerous | — |
| Desomorphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Dextromethorphan | Dangerous | — |
| GBL | Dangerous | — |
| GHB | Dangerous | — |
| MAOI | Dangerous | — |
| Naloxone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| 2-FA | Unsafe | — |
| 2-FMA | Unsafe | — |
| 3-FA | Unsafe | — |
| 3-FEA | Unsafe | — |
| 4-FA | Unsafe | — |
| 4-FMA | Unsafe | — |
| Alcohol | Unsafe | — |
| Amphetamine | Unsafe | — |
| Benzodiazepines | Unsafe | — |
| Cocaine | Unsafe | — |
| Dextroamphetamine | Unsafe | — |
| DOx | Unsafe | — |
| Fenethylline | Unsafe | — |
| Lisdexamfetamine | Unsafe | — |
| MDMA | Unsafe | — |
| Methamphetamine | Unsafe | — |
| PMA | Unsafe | — |
| 3-Cl-PCP | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-HO-PCE | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-HO-PCP | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-MeO-PCE | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-MeO-PCMo | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| Acetylfentanyl | Uncertain | — |
| Buprenorphine | Uncertain | — |
| Caffeine | Uncertain | — |
| Codeine | Uncertain | — |
| Dextropropoxyphene | Uncertain | — |
History
PCP was first synthesized in 1926 by German chemist Arthur Kotz and his student Paul Merkel at the University of Stuttgart, produced as a byproduct of a Grignard reaction during routine organochemical research. The compound sat in obscurity for three decades, an academic curiosity with no known application, until it was independently re-synthesized in 1956 by chemist H. Victor Maddox at Parke-Davis pharmaceutical company in Detroit.
Parke-Davis recognized PCP's potential as a surgical anesthetic. It was a genuine innovation: unlike barbiturates and ether, PCP maintained respiratory and cardiovascular function during anesthesia, eliminating the most dangerous complications of general anesthesia at the time. The company conducted clinical trials and brought PCP to market as Sernyl in the late 1950s. The results were initially promising. And then the patients began waking up.
Postoperative emergence reactions were severe and frequent. Patients recovering from PCP anesthesia experienced psychosis, agitation, delirium, paranoid hallucinations, and extreme dysphoria that could persist for days to weeks. In one early trial, roughly one-sixth of patients given anesthetic doses developed acute psychotic episodes. Subanesthetic doses used for pain management produced similar (though generally less severe) psychiatric disturbances. By 1965, Parke-Davis had discontinued PCP for human use. It remained available for veterinary anesthesia under the trade name Sernylan until 1978, when veterinary use was also terminated.
PCP entered the street drug supply in the late 1960s, initially sold under the name "PeaCe Pill" (a play on its chemical initials). By the mid-1970s it had acquired the name "angel dust" and was being sold primarily as a powder or liquid applied to leafy material (marijuana, mint, parsley) for smoking. The 1970s and 1980s represented the peak of PCP's street prevalence, particularly in Washington DC, Los Angeles, and other major US cities. Media coverage was intense and often sensationalized, focusing on violent incidents involving PCP-intoxicated individuals and contributing to a public mythology that exceeded the drug's already considerable dangers.
PCP was reclassified from Schedule III to Schedule II in 1978 in recognition of its high abuse potential and severe adverse effects. Street use declined through the 1990s and 2000s but never disappeared, persisting in specific communities and experiencing periodic regional resurgences.
PCP's scientific legacy extends far beyond its failed medical career. In the 1980s and 1990s, researchers discovered that PCP produced a remarkably complete model of schizophrenia in healthy volunteers -- reproducing not only positive symptoms (hallucinations, delusions, paranoia) but also negative symptoms (social withdrawal, flat affect, cognitive deficits) and cognitive symptoms (disorganized thinking, memory impairment). No other drug class accomplishes this. This observation was instrumental in developing the glutamate hypothesis of schizophrenia, which proposes that NMDA receptor hypofunction is a core mechanism of the disorder. The glutamate hypothesis became one of the most influential frameworks in psychiatric research and led directly to the investigation of ketamine as a rapid-acting antidepressant -- a line of research that produced esketamine (Spravato), FDA-approved for treatment-resistant depression in 2019.
Ketamine itself was developed in 1962 by Calvin Stevens at Parke-Davis specifically as a shorter-acting, less psychosis-inducing alternative to PCP -- making ketamine, in a very real sense, PCP's safer child. The entire modern landscape of dissociative research chemicals -- MXE, 3-MeO-PCP, DCK, 2-FDCK, and dozens of others -- exists in PCP's pharmacological lineage.
Harm Reduction
Understand What You Are Dealing With
PCP is among the most unpredictable and dangerous recreational dissociatives due to three converging factors: potent D2 dopamine agonism (producing mania and psychosis), complete pain abolition (removing the body's damage signals), and extreme lipophilicity (producing long, unpredictable duration with potential recurrence). Treat it with corresponding seriousness.
Dosing: Milligram Scale, No Exceptions
PCP has a steep dose-response curve and enormous individual variability. A milligram scale is mandatory.
- Low dose: 1-5 mg -- dissociative stimulation, numbness, mood elevation
- Common dose: 5-10 mg -- significant dissociation, mania risk begins
- High dose: 10-20 mg -- strong dissociation, psychosis risk escalates sharply
- Dangerous: 20+ mg -- severe psychosis, catatonia, medical emergency territory
The margin between "stimulating and euphoric" and "psychotic and dangerous" is narrower than with any other common dissociative. Start at 1-3 mg if you have no tolerance.
Never Use Alone
A sober sitter is not optional with PCP -- it is essential. PCP can produce violent, erratic behavior, complete breaks from reality, and a total inability to recognize danger. The sitter should be someone who has read about PCP's effects and understands that the user may become physically aggressive, verbally grandiose, or attempt to leave the environment. The sitter should not attempt to physically restrain a PCP-intoxicated person unless there is imminent danger of serious injury -- PCP abolishes pain and can produce remarkable physical endurance that makes restraint dangerous for both parties.
Secure the Environment
Before any PCP session, remove or secure: weapons, sharp objects, car keys, heights (lock windows on upper floors), and access to bodies of water. PCP-related fatalities from trauma (falls, drowning, self-injury without pain awareness) significantly exceed fatalities from the drug's direct pharmacological toxicity.
Route Matters
Smoking (PCP applied to leaf material -- mint, parsley, marijuana) is the most common street route and provides the fastest onset but the least dose control. If the material is of unknown potency, a single small puff followed by a 15-minute wait is the safest approach. Oral dosing allows more precise measurement but has a longer, harder-to-gauge onset (30-60 minutes) that tempts premature redosing.
Do Not Combine
- Stimulants (amphetamine, cocaine, MDMA) -- dramatically amplifies mania, cardiovascular stress, and psychosis risk. This combination is extremely dangerous
- Alcohol -- unpredictable potentiation of both sedation and disinhibition, aspiration risk
- Opioids -- PCP can reduce opioid tolerance, increasing overdose risk. Respiratory depression compounds
- Other dissociatives -- additive NMDA blockade with unpredictable effects
- Cannabis -- frequently intensifies paranoia and psychotic features
- Benzodiazepines -- potentiate ataxia and sedation; memory blackouts likely. However, benzodiazepines are used medically to manage PCP-induced agitation
Duration and Lipophilicity
PCP effects last 4-8 hours acutely but residual effects can persist for 24-48 hours or longer. The drug accumulates in fat tissue and can produce unexpected recurrence of effects ("flashbacks") as it mobilizes from adipose stores over the following days. Do not plan any activities requiring judgment, coordination, or driving for at least 24 hours after use. Chronic users may experience PCP-related effects for days to weeks after their last dose.
If Someone Is Experiencing PCP-Induced Psychosis
Keep the environment calm, quiet, and low-stimulation. Do not argue with their delusions. Do not attempt physical restraint unless necessary for immediate safety. Speak in short, calm, reassuring sentences. Call 911 if the person is a danger to themselves or others, is experiencing seizures, or has a very high temperature.
Toxicity & Safety
Acute Physical Toxicity
PCP's most dangerous acute effects are dose-dependent and include severe hypertension (which can cause stroke or intracranial hemorrhage), hyperthermia (body temperature can exceed 40°C/104°F), rhabdomyolysis (skeletal muscle breakdown that releases myoglobin into the bloodstream, potentially causing acute kidney failure), seizures, and respiratory depression at very high doses. The pain abolition produced by PCP means that users may sustain fractures, lacerations, and burns without awareness, and the manic agitation can produce extreme muscular exertion that overwhelms the body's thermoregulatory and metabolic capacity.
Psychosis and Mania
PCP produces psychosis at a significantly higher rate than any other commonly used dissociative. The combination of NMDA antagonism, D2 dopamine agonism, and sigma receptor activity creates a uniquely psychotomimetic pharmacological profile. PCP-induced psychosis can manifest as paranoid delusions, grandiose delusions, hallucinations, severe agitation, catatonia, and complete loss of reality testing. In clinical trials, one-sixth of patients receiving anesthetic doses developed acute psychotic episodes. At recreational doses, psychosis risk correlates with dose, frequency of use, and individual predisposition (family history of psychotic disorders, prior psychotic episodes).
PCP-induced psychosis typically resolves within days to two weeks of last use but in some cases has persisted for weeks to months, and there is evidence that PCP can precipitate lasting psychotic disorders in predisposed individuals. Chronic PCP use has been associated with schizophrenia-like presentations including disorganized thinking, flat affect, social withdrawal, and persistent cognitive deficits.
Behavioral Risk and Trauma
A substantial proportion of PCP-related deaths are not from the drug's direct toxicity but from trauma sustained during intoxication. Falls from heights, drowning, self-inflicted injuries (without pain awareness), automobile accidents, and injuries sustained during encounters with law enforcement account for a significant share of PCP fatalities. The combination of pain abolition, manic agitation, impaired judgment, and remarkable physical endurance creates a profile of behavioral risk that exceeds any other recreational dissociative.
Rhabdomyolysis
PCP-induced rhabdomyolysis is a well-documented and potentially life-threatening complication. The mechanism involves a combination of extreme muscular exertion (from agitation and manic activity), hyperthermia, and possibly direct toxic effects on muscle tissue. Rhabdomyolysis releases myoglobin and creatine kinase into the bloodstream, which can cause acute kidney failure. This is a medical emergency requiring aggressive IV fluid resuscitation.
Neurotoxicity
PCP administration produces Olney's lesions (vacuolar changes in specific brain regions) in rats, though these were found to be reversible at non-lethal doses. The relevance to human use is uncertain. PCP has been shown to alter N-acetylaspartate and N-acetylaspartylglutamate levels in rat brains, markers associated with neuronal integrity. Chronic PCP users frequently exhibit lasting cognitive deficits including memory impairment, executive dysfunction, and disorganized thinking, though distinguishing direct neurotoxicity from the consequences of repeated psychotic episodes is difficult.
Urinary Tract Effects
Chronic heavy PCP use produces bladder and urinary tract pathology similar to ketamine-induced cystitis: urinary frequency, urgency, incontinence, pelvic pain, and hematuria. These effects are cumulative with repeated use and are believed to result from direct irritant effects of PCP and its metabolites on the urothelium.
Dependence
PCP is moderately to highly addictive. It is self-administered in animal models and induces neuroplastic changes in reward circuitry (delta-FosB expression in nucleus accumbens D1-type medium spiny neurons). Tolerance develops with repeated use; psychological dependence can be intense. Withdrawal produces dysphoria, irritability, depression, and craving. Among dissociatives, PCP is generally rated as having higher addiction potential than ketamine, MXE, or diphenidine.
Addiction Potential
PCP is moderately to highly addictive, with a dependence potential that exceeds most other dissociatives. In animal models, PCP is reliably self-administered, and chronic exposure induces delta-FosB expression in D1-type medium spiny neurons of the nucleus accumbens -- the same neuroplastic marker associated with cocaine and amphetamine dependence. The rewarding effects of PCP are mediated through a dual mechanism: NMDA receptor blockade of glutamatergic inputs to the nucleus accumbens (shared with other dissociatives) and direct D2 dopamine receptor agonism (unique to PCP among common dissociatives). This dopaminergic component is likely why PCP's addiction potential is higher than ketamine's or MXE's -- it engages reward circuitry more directly and more powerfully. Tolerance develops with repeated use, requiring escalating doses for equivalent effects. Tolerance to half baseline resets in approximately 3-7 days; full baseline recovery takes 1-2 weeks. Cross-tolerance exists with all dissociatives. Psychological dependence can be intense, driven by the euphoria, sense of power, and anxiety abolition that PCP produces. Withdrawal manifests as dysphoria, irritability, depression, cognitive impairment, and intense craving. The withdrawal is not physically dangerous in the way alcohol or benzodiazepine withdrawal can be, but the psychological component can be severe and prolonged. Chronic PCP dependence is associated with escalating psychiatric complications: increasing frequency and severity of psychotic episodes, progressive cognitive decline, social deterioration, and personality changes. The lipophilic storage of PCP in adipose tissue complicates recovery, as the drug can continue to mobilize from fat stores for weeks after the last dose, producing intermittent recurrence of effects and craving. Community reports and clinical literature both describe PCP dependence as one of the more difficult dissociative addictions to recover from, owing to the intensity of the rewarding effects, the severity of psychological withdrawal, and the persistent cognitive consequences of chronic use.
Overdose Information
PCP overdose is a medical emergency that can be fatal. The most dangerous complications are seizures, stroke (from severe hypertension), hyperthermia, rhabdomyolysis leading to kidney failure, respiratory depression, and trauma from psychosis-driven behavior.
Recognizing PCP Overdose
- Seizures (generalized tonic-clonic)
- Unresponsiveness or coma
- Extremely high blood pressure (stroke risk)
- Very high body temperature (hyperthermia above 40°C/104°F)
- Rapid horizontal or vertical nystagmus (involuntary eye movements)
- Severe muscle rigidity
- Violent, bizarre, or catatonic behavior
- Apparent insensitivity to pain with self-injurious behavior
- Dark or reduced urine output (rhabdomyolysis sign)
Emergency Response
- Call 911 immediately. PCP overdose requires hospital-level management. Be specific: "The person may have taken PCP. They are [describe symptoms]." Good Samaritan laws protect you
- Do not attempt physical restraint unless the person is in immediate danger of severe injury (falling from height, entering traffic). PCP abolishes pain and produces extreme endurance -- restraint attempts can injure both parties and can worsen rhabdomyolysis
- Reduce stimulation. Quiet environment, dim lights, calm voices. Sensory stimulation worsens PCP-related agitation
- If seizing, protect the head. Do not put anything in the mouth. Time the seizure. Call 911 if not already done
- If unresponsive and not breathing, begin CPR
- Monitor temperature. If the person feels extremely hot, apply cool water to skin and move to a cooler environment while waiting for emergency services
Hospital Management
In the emergency department, first-line treatment for PCP agitation is benzodiazepines (typically IV lorazepam or diazepam). Active cooling is used for hyperthermia. Aggressive IV fluid resuscitation is critical if rhabdomyolysis is suspected (to protect the kidneys). Urine acidification -- once recommended to accelerate PCP excretion -- is no longer used because it worsens rhabdomyolysis-induced kidney damage. Seizures are treated with benzodiazepines. Severe hypertension may require IV antihypertensives. Physical restraint in medical settings follows specific protocols to minimize rhabdomyolysis risk.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Tolerance
| Full | with prolonged and repeated use |
| Half | 3 - 7 days |
| Zero | 1 - 2 weeks |
Cross-tolerances
Legal Status
Internationally, PCP is a Schedule II substance under the Convention on Psychotropic Substances.
Austria - PCP is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).
Canada - PCP is controlled under the Controlled Drugs and Substances Act as a Schedule I substance.
Czech Republic: PCP is a Schedule II (List 5) substance. Sold exclusively with a prescription "marked with a blue stripe running from the lower left corner to the upper right corner" (§ 1, e), 2. of Nařízení vlády č. 463/2013 Sb.)
Germany - PCP is controlled under BtMG Anlage I, making it illegal to manufacture, import, possess, sell, or transfer it without a license.
New Zealand - PCP is Schedule I (class A) in New Zealand.
Poland - PCP is listed under "Wykaz środków odurzających i substancji psychotropowych[" (II-P group) in Poland, and is illegal to posses, sell and manufacture.
Portugal - PCP is a Table-II-A substance under Decree-Law 15/93: Anti-Drug Legislation. PCP was decriminalized for personal use by Law 30/2000, but consumption or possession is still prohibited. The substance is liable to be seized and the possessor can be referred to mandatory treatment.
Switzerland: - PCP is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.
United Kingdom - PCP is controlled under the Misuse of Drugs Act as a Schedule II Class A drug, making it illegal to possess without a prescription.
United States - PCP is controlled under the Controlled Substances Act as a Schedule II controlled substance, making it illegal to possess without a prescription.
Experience Reports (6)
Tips (10)
Have a sitter present when using PCP, especially at higher doses. Dissociated individuals may wander, fall, or injure themselves without realizing it. A sober person can prevent physical accidents.
PCP has a much longer duration and more stimulating profile than ketamine or DXM. High doses do not produce a clean 'hole' like ketamine; instead they can cause agitation, psychosis, and complete loss of behavioral control. This is not a substance where you can safely push the dose.
Never use PCP near water (bathtubs, pools, lakes). Dissociation and water are a deadly combination. Loss of body coordination and awareness while near water has caused drownings.
If choosing between PCP analogues, 3-MeO-PCP is more functional at low doses but carries significant mania risk at higher doses. DCK is more sedating and hole-friendly. Neither should be combined with stimulants or serotonergic drugs. Always use a milligram scale.
PCP produces unpredictable behavioral responses at higher doses including severe agitation, self-harm, and extreme strength. The dissociative anesthesia means users may not feel pain from serious injuries.
The moreish quality of many dissociatives including PCP makes compulsive redosing common. Pre-measure your intended dose and put the rest away. A timed lockbox can help prevent impulsive additional doses.
Community Discussions (2)
Further Reading
Hamilton Morris
American chemist, journalist, and filmmaker whose documentary series Hamilton's Pharmacopeia brought rigorous scientific storytelling about psychoactive substances to mainstream television.
Read articleHamilton's Pharmacopeia
Hamilton Morris's Vice docuseries combines gonzo journalism with genuine scientific rigor, following the filmmaker-chemist to jungles, clandestine labs, and university research centers in pursuit of the world's most fascinating psychoactive substances.
Read articleKetamine Therapy: How It Works, What to Expect & Side Effects
Ketamine therapy is being used to treat depression, PTSD, anxiety, and chronic pain. This guide covers how therapeutic ketamine works, the different administration routes (IV infusion, nasal spray, sublingual), what a session feels like, common side effects, risks, costs, and harm reduction considerations.
Read articleSee Also
References (4)
- Ketamine as a rapid antidepressant — Berman et al. Biological Psychiatry (2000)paper
- PubChem: PCP
PubChem compound page for PCP (CID: 6468)
pubchem - PCP - TripSit Factsheet
TripSit factsheet for PCP
tripsit - PCP - Wikipedia
Wikipedia article on PCP
wikipedia